Staph fears prompt nasal spray recall
A batch of Metagenics NasoClear 30 mL nasal spray is being recalled due to concerns it may contain golden staph.
The TGA and Health Wolrd Limited have announced that batch number 80789 of Metagenics NasoClear 30 mL nasal spray (expiry May 2018) is being recalled.
It has been identified that some products from the affected batch may contain Staphylococcus aureus, commonly known as golden staph.
This particular batch has been supplied since 24 June 2016 and no other batches of Metagenics products are affected, the TGA says.
As of 20 September, no adverse events relating to this issue have been reported in Australia.
Health World Limited has written to health professionals who have stocked Metagenics NasoClear, providing them further information about this issue, including details of the recall process. They are also being provided a patient letter to assist in communicating this issue to consumers.
Pharmacists are advised to inspect any stock of Metagenics NasoClear to see if they are affected by this recall. If any are from batch number 80789, quarantine those products and arrange to return them to Health World Limited.
Consumers who have a product from this batch are advised to return it to the place of purchase for a credit.
Any questions or concerns about this issue are to be addressed to Health World Limited on 1800 777 648.
Click here for more information